Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
OSUR
#2938
OraSure Technologies Inc
3.1
5
+1.94%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.94%
Aylık değişim
+16.24%
6 aylık değişim
-5.69%
Yıllık değişim
-6.80%
Önceki kapanış
3.0
9
Open
3.1
5
Bid
Ask
Low
3.1
5
High
3.1
5
Hacim
50
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
OSUR
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
74.59 M
74.8 M
74.8 M
73.14 M
71.73 M
—
Valuation ratios
Enterprise value
39.95 M
2.27 M
4.51 M
-15.17 M
13.79 M
5.39 M
Price to earnings ratio
28.47
-13.88
-8.02
-4.41
-3.91
-30.23
Price to sales ratio
1.41
1.45
1.55
1.62
1.9
6.51
Price to cash flow ratio
4.63
9.82
6.23
5.24
5.94
27.23
Price to book ratio
0.19
0.65
0.15
0.14
0.15
1.1
Enterprise value to EBITDA ratio
3 994.6
-0.13
-0.16
0.35
-0.26
-0.2
Profitability ratios
Return on assets %
0.01
0.02
0.04
0.04
0.03
0.13
Return on equity %
0.01
0.03
0.04
0.05
0.04
0.16
Return on invested capital %
11.72
26.62
37.04
33.75
34
131.41
Gross margin %
42.77
36.23
41.09
42.12
43.46
162.9
Operating margin %
15.03
33.16
59.3
57.7
59.41
209.57
EBITDA margin %
-7.39
-26.51
-49.92
-49.61
-50.35
-176.38
Net margin %
11.29
28.83
53.59
63.03
50.63
196.08
Liquidity ratios
Quick ratio
11.2
8.93
10.94
6.33
6.2
32.4
Current ratio
12.6
9.95
12.34
7.12
7.03
36.44
Inventory turnover
0.59
0.65
0.5
0.52
0.46
2.14
Asset turnover
0.09
0.08
0.06
0.07
0.06
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.17
0
0.26
0.14
0.14
0.54
EBIT per share
-0.08
-0.17
-0.24
-0.24
-0.22
-0.86
EBITDA per share
-0.04
-0.13
-0.2
-0.21
-0.18
-0.72
Total debt per share
—
—
—
—
—
—
Cash per share
3.75
3.6
3.31
3.14
2.92
12.96
Net current asset value per share
4.71
4.48
4.19
4.04
3.82
16.52
Tangible book value per share
5.7
5.41
5.1
4.9
4.09
19.5
Working capital per share
4.34
4.03
3.85
3.47
3.27
14.62
Book value per share
5.73
5.51
5.29
5.1
4.88
20.79
OraSure Technologies Inc
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
Haberler
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
OraSure kazancı beklentilere uygun, kâr ise beklentilere göre düşük
OraSure earnings matched, revenue fell short of estimates
OraSure’s HIV self-test receives Health Canada license
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
Altai Capital, OraSure Technologies yönetim kurulu için iki direktör aday gösterdi
Altai Capital nominates two directors for OraSure Technologies board
Altai Capital, OraSure yönetim kuruluna endişeler nedeniyle iki direktör aday gösterdi
Altai Capital nominates two directors to OraSure board amid concerns
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure submits FDA applications for rapid STI test and collection device
NeoGenomics, tanı sektörü uzmanı Jack Kenny’yi yönetim kuruluna atadı